WASHINGTON (Reuters)—The collapse of Republicans’ push to repeal and replace Obamacare in the U.S. Senate set up a possible repeal-only vote and clouded the path forward for President Donald Trump’s other domestic policy goals, rattling financial markets on Tuesday. After two Republicans said they would not back the latest Obamacare rollback bill, Senate Majority Leader…
Articles by Natasha Yetman
Immune Response to Trauma May Flag Impending Organ Failure
NEW YORK (Reuters Health)—Early immune response signatures in the critically injured may shed light on mechanisms underlying multiple organ system failure, according to U.K. investigators. As Dr. Joanna M. Shepherd of Queen Mary University of London tells Reuters Health by email, “Multiple organ dysfunction syndrome (MODS) is common after major trauma and it contributes to…
Molecular Differences Between Pediatric & Adult Psoriasis Plaques
NEW YORK (Reuters Health)—The pathology of pediatric psoriasis differs from that of adult psoriasis, a finding that has implications for treatment, researchers suggest. “Pediatric psoriasis often differs from adult psoriasis in presentation, triggers, natural history, and response to therapy, suggesting potential differences in the pathophysiology of the disease processes,” Dr. Kelly Cordoro of the University…
Congress Must Shore Up Insurance Markets If Obamacare Repeal Fails
WASHINGTON (Reuters)—U.S. Senate Majority Leader Mitch McConnell (R-Ky.) said on Thursday that Congress must act to shore up private health insurance markets if it fails to repeal Obamacare, comments seen as providing a pathway to a bipartisan deal to fix the health system. Speaking at a luncheon in his home state of Kentucky, McConnell said,…
Changes in BMI Associated with Improvements in Disease Activity & Glucocorticoid Treatment
A recent study examined the relationship between increased BMI and antineutrophil cytoplasmic antibody–associated vasculitis treatment with glucocorticoids. The results: Weight gain was independently associated with reductions in disease activity, increased glucocorticoid exposure and randomization to rituximab. The most significant increases in BMI occurred during the first six months of treatment, and newly diagnosed patients were more likely to experience an increase in BMI…
Being Active May Reduce Risk of Chronic Low Back Pain
(Reuters Health)—Regularly engaging in physical activity, from walking to intense exercise, may help to reduce the risk of chronic low back pain by, as much as 16%, according to a new review of previous studies. In the past, it hasn’t been clear whether physical activity staves off low back pain, or people without back pain…
Stripping Americans of Health Insurance Could Be Deadly
(Reuters Health)—Health insurance saves lives—that’s the conclusion of a report released on Monday, just in time to weigh into the debate among Senate Republicans considering a bill that could strip millions of Americans of coverage. “Overwhelming scientific evidence shows that lack of insurance is sometimes deadly,” co-author Dr. David Himmelstein, a professor at the City…
U.S. Republican Leaders in Fierce Push for Senate Healthcare Vote
WASHINGTON (Reuters)—Republican leaders were in a fierce push on Tuesday to shore up support for a healthcare bill in the U.S. Senate after the nonpartisan Congressional Budget Office said 22 million Americans would lose insurance over the next decade under the measure. Vice President Mike Pence is expected to travel to Capitol Hill on Tuesday…
Psoriasis May Itch as Intensely as Atopic Dermatitis
NEW YORK (Reuters Health)—Itch intensity in moderate to severe plaque psoriasis can be substantial, and may be on a par with the notoriously itchy skin condition atopic dermatitis, new research suggests. “Both conventional wisdom and some of our classic dermatologic textbooks have stated that psoriasis is not particularly itchy,” corresponding author Dr. Alexa B. Kimball…
U.S. Supreme Court Speeds Copycat Biologic Drugs to Market
WASHINGTON (Reuters)—The U.S. Supreme Court on Monday cut the time it will take for copycat versions of biologic drugs to get to the market in a pivotal ruling about an expensive class of medicines that can yield billions of dollars in sales for drug companies. The justices, in a 9–0 ruling, overturned a lower court…
- « Previous Page
- 1
- …
- 42
- 43
- 44
- 45
- 46
- …
- 97
- Next Page »